BioCryst Pharmaceuticals BCRX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's total current assets?
- BioCryst Pharmaceuticals (BCRX) reported total current assets of $373.63M in Q1 2026.
- How has BioCryst Pharmaceuticals's total current assets changed year-over-year?
- BioCryst Pharmaceuticals's total current assets decreased by 8.9% year-over-year, from $409.98M to $373.63M.
- What is the long-term trend for BioCryst Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's total current assets has grown at a 4.5% compound annual growth rate (CAGR), from $323.8M to $404.35M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.